section name header
Index
35
45
ACE Inhibitors and Angiotensin II Receptor Blockers for Diabetics with Microalbuminuria
ACE Inhibitors and Angiotensin Receptor Blockers for Progression of Non-Diabetic Renal Disease
Adult
Adverse effects
Aged
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease
Amiodarone
Amoxicillin
Angiotensin-Converting Enzyme Inhibitors
Angiotensin Receptor Blockers or Angiotensin Converting Enzyme Inhibitors in the Prevention of Atrial Fibrillation
Anti-Bacterial Agents
Antibiotics
Antihypertensive Agents for Preventing Diabetic Kidney Disease
Antihypertensive Treatment for Kidney Transplant Recipients
Antiproteinuric and Renoprotective Effects of ACE Inhibitors and Angiotensin II Receptor Blockers
Atrial Fibrillation
Beta-Blockers Against other Antihypertensive Drugs
Beta-Blockers as Second-Line Therapy for Primary Hypertension
Beta-Blockers for Hypertension
Blood Pressure Lowering Efficacy of Renin Inhibitor Aliskiren for Primary Hypertension
Blood pressure
Calcium Channel Blockers
Cardiology
Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
Chronic kidney disease
Ciprofloxacin
Cochrane review
Cohort study
Combining ACE Inhibitors and Angiotensin Receptor Blockers in Renal Disease
Corticosteroids in Iga Nephropathy
Death
Diabetes
Diarrhoea
Diastolic blood pressure
Dietary Sodium Restriction, Blood Pressure and Cardiovascular Morbidity
Disease
Drugs for Chronic Heart Failure with Preserved Ejection Fraction
Drugs
Drug Therapy
Drug Treatment for Hypertension - Related Resources
Drug
Dual Alpha and Beta Blockers for Primary Hypertension
Elderly
Enzyme Inhibitors
Evidence summary
Exposure
Fatigue
Female
Female
First-Line Renin Angiotensin System Inhibitors Versus other Drug Classes for Hypertension
Follow-up
Geriatrics
Geriatrics
Headache
Heart
Hospitalization
Hypertension
Infection
Injury
Internal medicine
Internal medicine
Kidney
Morbidity
Mortality
Myocardial infarction
Nitrofurantoin
Non-Immunosuppressive Treatment for Iga Nephropathy
Nsaids and Blood Pressure
Patients
Pressure
Recurrence
Renin
Risk
Sensitivity
Spironolactone for Hypertension
Spironolactone
Stroke
Systematic review
The Impact of Suppressing the Renin-Angiotensin System on Atrial Fibrillation
Trimethoprim or Trimethoprim-Sulfamethoxazole and Risk of Hyperkalaemia Among Patients Taking Renin-Angiotensin System Blockers
Trimethoprim-Sulfamethoxazole and Risk of Sudden Death Among Patients Taking Renin-Angiotensin System Blockers
Trimethoprim-sulfamethoxazole
Trimethoprim
Urinary Tract
UTI
Women